Xerox Stock Falls On Unusually High Volume (XRX)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Xerox Corporation (NYSE: XRX) is trading at unusually high volume Tuesday with 41.2 million shares changing hands. It is currently at four times its average daily volume and trading down 33 cents (-4.7%) at $6.70 as of 3:55 p.m. ET.

  • ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.

Xerox has a market cap of $9.12 billion and is part of the consumer goods sector and consumer durables industry. Shares are down 11.7% year to date as of the close of trading on Monday.

Xerox Corporation provides business process and information technology (IT) outsourcing, and document management services worldwide. The company has a P/E ratio of 7.8, equal to the average consumer durables industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Xerox as a hold. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including weak operating cash flow, a generally disappointing performance in the stock itself and unimpressive growth in net income. You can view the full Xerox Ratings Report.

See all heavy volume stocks in our stocks moving on unusual volume list or get investment ideas from our investment research center.

FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.
null

If you liked this article you might like

Biotech Gold Rush Starts to Pick Up; Xerox, Fujifilm Saga Continues -- ICYMI

Biotech Gold Rush Starts to Pick Up; Xerox, Fujifilm Saga Continues -- ICYMI

Xerox's Jacobson Defends Fuji Deal As Icahn Hovers

Xerox's Jacobson Defends Fuji Deal As Icahn Hovers

Big Xerox Investor Sues to Block Fuji Deal

Big Xerox Investor Sues to Block Fuji Deal

Carl Icahn Urges Xerox Shareholders to Block Fuji Deal

Carl Icahn Urges Xerox Shareholders to Block Fuji Deal

Cramer: Hunting for Bargains

Cramer: Hunting for Bargains